PD‑L1 by IHC, SP263, TECENTRIQ®
Also known as: Programmed Death Ligand 1, VENTANA PD-L1 (SP263)
Use
The PD-L1 (SP263) is a qualitative assay intended for use in the detection of PD-L1 in formalin-fixed, paraffin embedded (FFPE) in non-small-cell lung cancer tissue samples using the Ventana BenchMark Ultra Platform.
Special Instructions
PD‑L1 testing will be delayed if the pathology report is not received. The test number is used for tracking oncology IHC specimens to the laboratory; bill codes will be added when testing is complete, based on the processes performed in the laboratory.
Limitations
Not provided.
Methodology
Immunoassay (IHC)
Biomarkers
Result Turnaround Time
6-10 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
At least two unstained slides sectioned at 4 microns, less than two months of sectioning if stored at 15°C to 30°C. Four slides ideal.
Minimum Volume
Two unstained slides at 4 microns, less than two months of sectioning if stored at 15°C to 30°C.
Container
Paraffin block or unstained positive charged slides
Collection Instructions
Paraffin block or unstained slides sectioned if stored at 15°C to 30°C for two months age.
Storage Instructions
Refrigerate.
Causes for Rejection
Slides sectioned greater than two months prior to test request and not stored at 15°C to 30°C.